The second one, as a consequence of a chronic inflammation in obesity, driven by excessive release of pro-inflammatory cytokines, diminishes receptor sensitivity and disrupts downstream signaling cascades, reducing leptin efficacy [43]. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.